Copyright
©The Author(s) 2020.
World J Gastrointest Oncol. Feb 15, 2020; 12(2): 182-194
Published online Feb 15, 2020. doi: 10.4251/wjgo.v12.i2.182
Published online Feb 15, 2020. doi: 10.4251/wjgo.v12.i2.182
Figure 2 The treatment efficacy was consistently similar in both groups across the majority of subgroups.
A: Forest plots of hazard ratio for overall survival; B: Progression-free survival according to subgroups.
- Citation: Cho IR, Kang H, Jo JH, Lee HS, Chung MJ, Park JY, Park SW, Song SY, An C, Park MS, Bang S. FOLFIRINOX vs gemcitabine/nab-paclitaxel for treatment of metastatic pancreatic cancer: Single-center cohort study. World J Gastrointest Oncol 2020; 12(2): 182-194
- URL: https://www.wjgnet.com/1948-5204/full/v12/i2/182.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v12.i2.182